Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 10 01; 24(19):4734-4744.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Bevacizumab
Clinical Trials as Topic
Equilibrative Nucleoside Transporter 1
Female
Genetic Predisposition to Disease
Genome-Wide Association Study
HSP90 Heat-Shock Proteins
Human Umbilical Vein Endothelial Cells
Humans
Hypertension
Male
Middle Aged
Neoplasms
Neovascularization, Pathologic
Vascular Endothelial Growth Factor A

authors with profiles

Mark J. Ratain